Instil Bio (UK) Limited

To investigate the generation of a type of stem cell from cancer specific immune cells, to isolate rarer cell populations from cancers and develop a treatment with enhanced activity and potentially develop this as a treatment that can be used to treat many patients.

Tumour infiltrating lymphocytes (TILs) hold great promise as the basis of treatment for solid cancers. They target cancer specific mutations and are thus truly specific, reducing risk of toxicities and their polyclonal nature limits the emergence of resistance to therapy. TIL therapy has been tested extensively in melanoma and recent establishment of Adva...

"**Advance Therapy Medicinal Products (ATMPs)** **are a new generation of treatments which use patients' cells as 'drugs' to treat a variety of diseases.** Although encouraging results have been reported, this technology is complex, expensive and currently only available to small numbers of patients. In **2018** the **UK** have formed **a network of three...

"Advance Therapies are a new generation of treatments which use patients' cells as 'drug' to treat a variety of diseases. Although encouraging results have been reported, this technology is complex, expensive and currently only available to small numbers of patients. We have formed the Innovate Manchester Advanced Therapy Centre Hub (iMATCH); this is a gr...

"ATMPs, which can be _cell or gene therapies_, show great potential in treating patients with conditions that cannot be cured with current treatments. These include arthritis, liver disease, several types of cancer, and diabetic ulcers. ATMPs are just beginning to be available, with the UK playing a leading role. However, even when new ATMP therapies are ...

Cell-derived products have potential as promising therapeutic approaches for the treatment of a wide range of conditions (e.g. neurodegenerative disorders, cancer, cardiac failure). Cell therapies require large scale supplies of viable cells at high purity levels, driving advancements in cell separation technologies to address downstream processing bottle...

"The need for new treatment options for cancer remains high. Recently there has been huge interest and massive success with treatments which involve modifying the patients immune system, effectively helping the patient fight their own cancer. In one example this has taken the form of drugs which can be injected, such as therapeutic antibodies. We and othe...

Cancer specific Adoptive T-Cell therapy (ACT) is a form of personalised medicine that harnesses the power of the patient's immune system to direct tumour-specific T-cells to kill cancer cells. The field of adoptive T-cell therapy has approached a point where the pre-clinical promise is now a clinical reality. Since the first report of use of TIL therapy i...

Within the UK, melanoma incidence rates have increased more rapidly than any of the 10 most common cancers in the past 30 years, with a 518% increase in males & 253% in females. Best in-class immunotherapy for metastatic melanoma is checkpoint inhibitors (nivolumab, ipilimumab) however limitations such as high chance or relapse, high cost & severe toxicit...